Epirubicin (E)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Epirubicin (E), covering 2019-10-25 to 2019-10-25. Get the full timeline:
Most recent: Clinical Trial Update: EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer [Phase 3]